
Experts urge pandemic cooperation that benefits developing countries
An analysis shows various scenarios for how COVID-19 is likely to play out around the world, widening inequalities.
Already have an account? Log in
An analysis shows various scenarios for how COVID-19 is likely to play out around the world, widening inequalities.
Prompted by its own paralysis over Syria and Ukraine, the U.N. moved to prevent abuse of power by Russia and other permanent Security Council members.
The world's biggest and most powerful atom smasher is once again circulating beams of protons for scientific discoveries.
Hackers gained access to ICRC confidential information about more than half a million 'highly vulnerable people.'
A Swiss science diplomacy foundation wants to prevent a new Cold War from being fought over science and technology.
Michelle Bachelet said reports about the use of Pegasus software for spying 'seem to confirm some of the worst fears.'
The U.N. approved a compromise to keep open Syria's last non-government controlled border crossing for aid.
Despite the pandemic, the number of people fleeing for safety around the world rose to almost 82.4 million last year.
With U.S.-Russia tensions nearing Cold War-era dimensions, the leaders turned to Swiss diplomacy to improve relations.
Ten U.N. agencies use blockchain and most others plan to despite environmental issues, data privacy, and cyber risks.
Machine learning applications that use big data are increasingly helping central banks, according to BIS.
International donors contributed US$1.7 billion for people starving in Yemen, an amount that leaders of humanitarian organizations called disappointing.
The COVAX Facility's global rollout of COVID-19 vaccines finally launched with the delivery of 600,000 doses to Ghana's capital Accra.
Ten million pages scanned, five million more to go. The digitization project for the archives hit the two-thirds mark.
Rich countries locked up most of the COVID-19 vaccine supply despite the COVAX Facility's efforts to provide equal access.
A two-shot vaccine from BioNTech and Pfizer gained official approval in the E.U., two days after Switzerland approved it through a normal procedure.